» Articles » PMID: 21261806

Mechanisms Underlying FeCl3-induced Arterial Thrombosis

Overview
Publisher Elsevier
Specialty Hematology
Date 2011 Jan 26
PMID 21261806
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The FeCl(3)-induced vascular injury model is widely used to study thrombogenesis in vivo, but the processes leading to vascular injury and thrombosis are poorly defined.

Objectives: The aim of our study was to better characterize the mechanisms of FeCl(3)-induced vascular injury and thrombus formation, in order to evaluate the pathophysiological relevance of this model.

Methods: FeCl(3) was applied at different concentrations (from 7.5% to 20%) and for different time periods (up to 5 min) to mouse carotid or mesenteric arteries.

Results: Under all the conditions tested, ultrastructural analysis revealed that FeCl(3) diffused through the vessel wall, resulting in endothelial cell denudation without exposure of the inner layers. Hence, only the basement membrane components were exposed to circulating blood cells and might have contributed to thrombus formation. Shortly after FeCl(3) application, numerous ferric ion-filled spherical bodies appeared on the endothelial cells. Interestingly, platelets could adhere to these spheres and form aggregates. Immunogold labeling revealed important amounts of tissue factor at their surface, suggesting that these spheres may play a role in thrombin generation. In vitro experiments indicated that FeCl(3) altered the ability of adhesive proteins, including collagen, fibrinogen and von Willebrand factor, to support platelet adhesion. Finally, real-time intravital microscopy showed no protection against thrombosis in GPVI-immunodepleted and β(1)(-/-) mice, suggesting that GPVI and β(1) integrins, known to be involved in initial platelet adhesion and activation, do not play a critical role in FeCl(3)-induced thrombus formation.

Conclusion: This model should be used cautiously, in particular to study the earliest stage of thrombus formation.

Citing Articles

Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia.

Lee R, Ballard-Kordeliski A, Jones S, Bergmeier W Res Pract Thromb Haemost. 2025; 9(1):102672.

PMID: 39902096 PMC: 11788864. DOI: 10.1016/j.rpth.2024.102672.


Modulates Platelet Aggregation and Thrombus Formation by Regulating the Glycoprotein VI-Mediated Signalosome in Mice.

Kim Y, Kim T, Lee A, Kim K, Hwang Y Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38275992 PMC: 10819422. DOI: 10.3390/ph17010006.


Animal Models of Ischemic Stroke with Different Forms of Middle Cerebral Artery Occlusion.

Zeng L, Hu S, Zeng L, Chen R, Li H, Yu J Brain Sci. 2023; 13(7).

PMID: 37508939 PMC: 10377124. DOI: 10.3390/brainsci13071007.


Loss of zinc transporters ZIP1 and ZIP3 augments platelet reactivity in response to thrombin and accelerates thrombus formation .

Elgheznawy A, Oftering P, Englert M, Mott K, Kaiser F, Kusch C Front Immunol. 2023; 14:1197894.

PMID: 37359521 PMC: 10285393. DOI: 10.3389/fimmu.2023.1197894.


Vagus nerve stimulation primes platelets and reduces bleeding in hemophilia A male mice.

Bravo-Iniguez C, Fritz J, Shukla S, Sarangi S, Thompson D, Amin S Nat Commun. 2023; 14(1):3122.

PMID: 37264009 PMC: 10235098. DOI: 10.1038/s41467-023-38505-6.